Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
ReViral Ltd
1674
ReViral Ltd
Technology
Biotechnology
Health Care
Medical
Therapeutics
ReViral is a UKbased biotechnology company developing firstinclass drugs to treat RSV infections.
Suggest edits
Type
B2c
Founded
2011
Raised
$99M
Follow us
Also headquartered in London
Blockchain
Reuters
Springwise
BBC
DeepMind
Revolut
HSBC
Volkswagen
Cambridge Analytica
Ubuntu
Companies in the same industry
Seattle Genetics
Merus
Pinteon Therapeutics Inc.
Turnstone Biologics
Cedilla Therapeutics
IMMT - Institute of Metagenomics...
Kriya Therapeutics
Neogene Therapeutics
Carmot Therapeutics, Inc.
Biomoti
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$44,000,000
Venture capital (Series C) - 2020
New Leaf Venture Partners
Perceptive Advisors
OrbiMed Advisors
+5
$55,000,000
Venture capital (Series B) - 2018
New Leaf Venture Partners
Perceptive Advisors
OrbiMed
+3
Team Size
1–10
Employees
I work here
Location
London
,
United Kingdom
Headquarters
Explore London
$44,000,000
Venture capital (Series C)
FinSMEs
ReViral Raises $44M in Series C Financing
PE HUB
VC-backed ReViral taps Musso as CFO
$55,000,000
Venture capital (Series B)
MedCity News
,
FinSMEs
,
PE HUB
ReViral closes $55 million Series B funding round for RSV drug
